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Summary
Chronic inflammation is a contributing factor to most life shortening human diseases. However, 
the molecular and cellular mechanisms that sustain chronic inflammatory responses remain poorly 
understood making it difficult to treat this deleterious condition. Using a mouse model of age-
dependent inflammation that results from a deficiency in miR-146a, we demonstrate that miR-155 
contributed to the progressive inflammatory disease that emerged as Mir146a−/− mice grew older. 
Upon analyzing lymphocytes from inflamed versus healthy middle-aged mice we found elevated 
numbers of T follicular helper (Tfh) cells, germinal center (GC) B cells and autoantibodies, all 
occurring in a miR-155-dependent manner. Further, Cd4-cre Mir155fl/fl mice were generated and 
demonstrated that miR-155 functions in T cells, in addition to its established role in B cells, to 
promote humoral immunity in a variety of contexts. Taken together, our study discovers that 
miR-146a and miR-155 counter-regulate Tfh cell development that drives aberrant GC reactions 
during chronic inflammation.
Introduction
Chronic, low-grade inflammation is driven by sustained production of inflammatory factors 
such as cytokines, reactive oxygen species and autoantibodies, and is associated with 7 of 
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the top 10 causes of mortality in the United States such as heart disease, neurodegeneration, 
metabolic disorders, autoimmunity and cancer (Akbaraly et al., 2013; Howcroft et al., 2013; 
Michaud et al., 2013). This deleterious condition, which typically lacks clinical symptoms, 
can cause damage to important organ systems over time, and serve as a primer for many 
age-related disorders. Despite our growing knowledge of immune regulation during acute 
inflammatory responses, our understanding of molecular and cellular mechanisms governing 
chronic, low-grade inflammation remains tenuous. This deficiency has prevented the 
development of targeted therapies to reduce chronic inflammation and the plethora of 
disorders associated with one’s inflammatory status during the aging process. By the year 
2050 it is projected that those 60 years and older will make up 22% of the world’s 
population, compared to only 10% in the year 2000 (Dorshkind et al., 2009). Thus, finding 
therapeutic solutions to chronic inflammatory conditions has become more important than 
ever before.
It is now appreciated that most of the human genome is transcribed into noncoding RNAs 
that carry out diverse cellular functions including differentiation, survival and proliferation 
(Esteller, 2011). Among noncoding RNAs, microRNAs (miRNAs) regulate gene expression 
post-transcriptionally and have been shown to modulate a wide range of biological systems 
(Mendell and Olson, 2012). Further, several miRNAs have been shown to control 
inflammation in young mice subjected to infection by pathogens or during antigen-induced 
autoimmunity (Baumjohann et al., 2013; Kang et al., 2013; O'Connell et al., 2010b; Oertli et 
al., 2011; Rodriguez et al., 2007). Despite their emerging connection to acute inflammation, 
little is known about the functions of miRNAs during chronic inflammation and diseases 
associated with aging. Recently, the anti-inflammatory miR-146a has emerged as a 
molecular safeguard against age-dependent inflammatory disease (Boldin et al., 2011; Zhao 
et al., 2011; Zhao et al., 2013). Mice deficient in miR-146a have increased serum 
concentrations of interleukin-6 (IL-6) and autoantibodies, and display splenomegaly, 
myeloproliferation and inflammatory damage to several tissues as they reach middle age. 
When Mir146a−/− mice grow even older, they succumb to different types of cancers and 
hematopoietic neoplasms that reduce their lifespans compared to wild type (Wt) controls. 
These findings clearly demonstrate that specific miRNAs have evolved to regulate chronic, 
low-grade inflammation, and establish Mir146a−/− mice as an excellent model with which to 
study this clinically relevant condition. While miR-146a functions to prevent chronic 
inflammation, we hypothesized that other miRNAs act to promote this deleterious process.
miR-155 has emerged as a multi-faceted regulator of immunity that impacts different types 
of inflammatory responses in young mice (Hu et al., 2013; Huffaker et al., 2012; O'Connell 
et al., 2010b; Rodriguez et al., 2007; Thai et al., 2007). Further, previous studies find that 
constitutive overexpression of miR-155 in the hematopoietic compartment causes a chronic 
inflammatory disease (O'Connell et al., 2008) or leukemia (Costinean et al., 2006), 
shortening the animal’s lifespan. In the present study, we investigated the role of 
endogenous miR-155 during chronic, low-grade inflammation that develops in Mir146a−/− 
mice.
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miR-155-dependent accumulation of activated T cells in Mir146a−/− mice
To determine if endogenous miR-155 plays a role in promoting age-dependent disease in 
Mir146a−/− mice, we aged Mir155−/− Mir146a−/− (DKO) and control mice for 7–10 months 
(middle-age). As previously reported (Boldin et al., 2011; Zhao et al., 2011; Zhao et al., 
2013), middle-aged but not young Mir146a−/− mice had enlarged spleens (Figures 1A). 
Elevated amounts of activated T cells (CD4+CD69+CD62L−) were also evident in middle-
aged Mir146a−/− mice, both in the spleen and lymph nodes, and this activated T cell 
phenotype did begin to emerge in young mice (Figures 1B, 1C and S1). In contrast, middle-
aged Mir155−/− Mir146a−/− mice had spleen weights and activated CD4+ T cell levels that 
were similar to middle-aged Wt mice, indicating that miR-155 promotes these phenotypes in 
Mir146a−/− animals (Figures 1A–1C and S1).
The Mir146a−/− mouse phenotype is largely dependent upon lymphocytes (Zhao et al., 
2013), and consistent with previous work (Yang et al., 2012), we found that an increase in 
activated CD4+ T cells precedes other disease manifestations in this model (Figures 1C and 
S1). Using bone marrow reconstitution experiments we also determined that this phenotype 
was primarily hematopoietic in nature (Figure S1). Based upon these findings, we next 
assessed miR-155 expression in CD4+ T cells. Results showed that miR-155 expression 
trended towards being higher in CD4+ T cells from young Mir146a−/− mice, compared to 
Wt controls, and reached even higher expression in CD4+ T cells taken from middle-aged 
Mir146a−/− mice (Figure 1D). This correlated with an increased proportion of activated T 
cells in the bulk CD4+ T cell populations from Mir146a−/− versus Wt mice. Upon sorting, 
we confirmed that activated CD4+ T cells expressed higher miR-155 than naïve T cells, and 
this expression was enhanced further in activated T cells lacking miR-146a (Figure 1E). It 
has been previously demonstrated that activated Mir146a−/− CD4+ T cells have elevated NF-
κB activation, a pathway that we found to promote miR-155 expression in activated CD4+ T 
cells (Figure 1F). In contrast to T cells, enhanced expression of miR-155 was not observed 
in B220+ B cells from Mir146a −/− mice (Figure S1). Based on these results, we focused our 
subsequent analysis on the CD4+ T lymphocyte compartment to better understand the role of 
miR-155 during chronic inflammation.
Spontaneous T follicular helper cells, germinal center B cells and autoantibodies 
accumulate in Mir146a−/− mice
We examined gene expression patterns in CD4+ T cells from 10-month old Wt, Mir155−/−, 
Mir146a−/− and Mir155−/− Mir146a−/− mice by RNA-Seq. Gene expression profiles in 
Mir146a−/− CD4+ T cells were distinct from the other three genotypes according to a cluster 
analysis while Mir155−/− Mir 146a−/− profiles clustered closer to Mir155−/− than Wt or 
Mir146a−/− profiles (Figure 1G). IL-21 expression was significantly higher in Mir146a−/− 
compared to Wt middle-age CD4+ T cells, while there was little difference in interferon-γ 
(IFN-γ) mRNA amounts and undetectable expression of the IL-17A message in both 
genotypes (Figure 1H). IL-21 is produced by T follicular helper (Tfh) cells, and its elevated 
expression in Mir146a−/− T cells prompted us to examine additional Tfh genes. We 
observed increased expression of B cell lymphoma 6 protein (Bcl6), chemokine (C-X-C 
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motif) receptor 5 (Cxcr5), programmed cell death 1 (Pd1), and inducible T cell co-stimulator 
(Icos) (among others) in Mir146a−/− CD4+ T cells, and decreased or unchanged expression 
of these genes in Mir155−/− and Mir155−/− Mir146a−/− T cells, compared to Wt controls 
(Figure 1I). This was confirmed by quantitative rtPCR (QPCR) (Figure 1J). These data 
suggested that Mir146a−/− CD4+ T cells from middle-aged mice are enriched in Tfh cells, 
and that this occurs through a miR-155-dependent mechanism.
Using flow cytometry, we next detected increases in CD44+CD4+CXCR5+PD1+ Tfh cell 
numbers in the spleens and LNs of middle-aged Mir146a−/− mice compared to controls 
(Figures 2A, 2B and S2). Further, these cells also expressed ICOS and BCL6 consistent with 
their Tfh cell identity (Figures 2C–2E). miR-155 was expressed at higher amounts in Wt Tfh 
compared to non-Tfh cells, and further enhanced in Mir146a−/− Tfh cells (Figure 2F). This 
Tfh cell phenotype began to emerge in young Mir146a−/− mice, suggesting that it may be an 
early step in disease progression. We also observed an overall increase in Tfh cells in the 
CD4+ T cell compartment as a function of age in all groups (Figure 2G).
Tfh cells promote antibody class-switching and production by germinal center (GC) B cells 
(Johnston et al., 2009; Nurieva et al., 2008), and play established roles in driving 
autoimmunity when their development becomes dysregulated (Linterman et al., 2009). 
Consistent with this, increases in B220+IgDloFashiGL7hi GC B cells were observed in young 
and middle-age Mir146a−/− mice compared to controls, and elevations in GC B cells were 
also observed as a function of age in all groups (Figure 2H–J). Heightened serum 
concentrations of anti-dsDNA autoantibodies were detected in middle-aged mice, but unlike 
Tfh and GC B cells, not young Mir146a−/− mice (Figure 2K). This suggests that in some 
cases long-term GC reactions may be necessary for production of autoantibodies, which are 
associated with inflammation in a variety of autoimmune settings. Of relevance, this entire 
phenotype was dependent upon miR-155, as Mir155−/−Mir146a−/− mice resembled Wt or 
Mir155−/− animals in both age groups (Figures 2A–D, 2G–K and S2). These findings 
indicate that miR-155 is required for spontaneous Tfh cell development and aberrant 
humoral responses in Mir146a−/− mice.
miR-155 promotion of GC formation in Mir146a−/− mice precedes the onset of systemic 
tissue inflammation
To further assess the miR-155-dependent inflammatory disease that develops in Mir146a−/− 
mice, H&E stained splenic sections from Wt, Mir155−/−, Mir146a−/− and Mir155−/− 
Mir146a−/− mice at 1.5, 4 and 11 months of age were prepared (Figures 3A and S3). 
Immmunohistochemistry (IHC) was also performed on splenic sections from 1.5 month old 
mice to detect B (B220) and T (CD3) cells, and serial sections were also stained for BCL6 
(Figures 3B and S3). Peanut agglutinin (PNA) staining was also performed (Figure 3C). 
Histological analysis demonstrated the highest number GCs in Mir146a−/− spleens, reduced 
amounts in Wt mice and the lowest numbers in Mir155−/− and Mir155−/− Mir146a−/− mice 
at 1.5 and 4 months of age (Figures 3A–3D). The number of germinal centers increased with 
age in Wt and Mir146a−/− mice, but remained low in Mir155−/− and Mir155−/− Mir146a−/− 
mice. Consistent with this, there were increased numbers of BCL6+ and PNA+ cells in 
lymphoid follicles in Mir146a−/− spleens compared to spleens from the other genotypes 
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(Figure 3B, 3C and S3). All of these observations are concordant with our flow cytometry 
data, and further demonstrate that the aberrant GC phenotype in Mir146a−/− mice begins in 
young mice and becomes more severe with age.
By 11 months of age, Mir146a−/− spleens had disrupted lymphoid follicles that were 
replaced by increased myeloid cells and other hematopoietic elements, and this was 
generally not observed in the other age-matched genotypes (Figures 3A, 3E and S3). 
Further, inflammatory infiltrates into the liver and kidneys of Mir146a−/− mice were found 
by 12 months of age (Figure 3F), indicating a multi-organ inflammatory condition was 
emerging. In contrast, these features were not observed in the Mir155−/− Mir146a−/− mice 
analyzed suggesting that miR-155 promotes chronic inflammation in multiple tissues when 
miR-146a is absent.
miR-155 regulates Tfh cell development through a T cell intrinsic mechanism following 
immunization
Tfh cell formation involves both cell-intrinsic and -extrinsic mechanisms (Tangye et al., 
2013). To determine if miR-155 plays a cell-autonomous role in Tfh cell development, we 
created T cell-specific miR-155 deficient mice (Cd4-cre Mir155fl/fl) where the miR-155 
gene is floxed and Cre is driven by the CD4 locus (Figures 4A, 4B, Figure S4 and Table S1). 
In addition to confirming specific deletion of miR-155 in T cells (Figure 4C and S4), we 
also determined that Cd4-cre Mir155fl/fl mice and controls had similar percentages of CD4+, 
CD8+ and B220+ cells in the spleens under steady-state conditions (Figure S4). Next, we 
immunized Cd4-cre Mir155fl/fl mice and relevant controls with Ovalbumin (Ova) in 
complete freund’s adjuvant (CFA). After 8 days we measured the development of Tfh and 
GC B cells, and found that miR-155 expression was specifically required by T cells for 
proper development of these cell lineages in the spleen and lymph nodes (Figures 4D–4J and 
S5). Further, reduced anti-Ova IgG1 serum antibodies were detected in Cd4-cre Mir155fl/fl 
mice at multiple time points post-immunization (Figures 4K, 4L and S5), albeit amounts 
were not as low as in whole body Mir155−/− mice because miR-155 also functions in B cells 
(Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2013). Despite substantial 
reductions in GC phenotype B cells in the spleens of Cd4-cre Mir155fl/fl mice, only partial 
decreases in antigen specific antibodies were observed, perhaps reflecting contributions or 
compensation by extra follicular B cells. Together, our data demonstrate that miR-155 has a 
T cell-intrinsic role during Tfh cell development and the GC response.
miR-155 is required for early Tfh cell differentiation by antigen-specific, naïve CD4+ T cells
To gain further insight into the role of miR-155 during Tfh cell development, we crossed 
Mir155−/− mice with Smarta (SM) TCR Tg mice. Equal numbers of naïve splenic Wt or 
Mir155−/− SM cells were injected into Wt B6 recipients and mice were infected with 
Vaccinia virus expressing the lymphocytic choriomeningitis virus (LCMV) glycoprotein 
(VACV-gpc) recognized by SM T cells. Following 3 or 5 days of infection, Mir155−/− SM 
cells were defective in their production of CXCR5+PD1+ Tfh cells compared to Wt controls 
at both time points (Figures 5A–C). We also observed defective expression of BCL6 by 
Mir155−/− SM cells at the 3-day time point (Figure 5D, top). Mir155−/− SM cells 
demonstrated modest yet significant reductions in the proliferation marker Ki67 (Figure 5D, 
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bottom), suggesting that reduced proliferation could be contributing to their diminished 
numbers compared to Wt SM cells. Further, Mir155−/− CXCR5+PD1+ SM cells also 
displayed subtle defects in proliferation as assayed by loss of CFSE, as fewer cells had 
entered the 6th cell division by 3 days post-infection when compared to Wt controls (Figures 
5E and 5F). No difference in SM cell death was observed between the genotypes according 
to 7-AAD staining, and homeostatic amounts of SM cells were not reduced by a loss in 
miR-155 in the absence of infection (Figure S5). These data demonstrate that naïve, antigen-
specific CD4+ T cells require miR-155 for robust Tfh cell development at early stages 
during the response, and that miR-155 appears to influence both Tfh cell differentiation and 
expansion.
Identification of miR-155 targets in Tfh cells
To identify miR-155 target genes involved in Tfh cell development in the context of chronic 
inflammation we utilized an integrated approach (Figure S6). RNA was extracted from 
sorted Tfh cells isolated 8 days after immunizing Wt and Mir155−/− mice with Ova and 
expression of Bcl6 was confirmed in sorted Tfh compared to non Tfh cells by QPCR (Figure 
6A). The RNA was next subjected to RNA-Seq to profile gene expression in Wt and 
Mir155−/− Tfh cells, and cluster analysis revealed that the two genotypes had disparate 
profiles (Figure S6). However, expression of several Tfh-related genes was not significantly 
changed between Wt and Mir155−/− Tfh cells on a per cell basis, suggesting that miR-155 
regulates the quantity and not quality of Tfh cells (Figure S6). Among miR-155 target 
mRNAs predicted bioinformatically by Targetscan and determined experimentally using 
Ago HITS-CLIP (Loeb et al., 2012), we observed a bias towards higher expression of these 
genes in Mir155−/− versus Wt Tfh cells, consistent with miR-155 target genes being de-
repressed (Figures 6B and Table S2).
To identify candidate miR-155 target genes involved in Tfh cell formation during chronic 
inflammation we determined which miR-155 targets were 1) elevated in sorted Mir155−/− 
Tfh cells from immunized mice (Table S2), 2) elevated in middle-aged Mir155−/− and 
Mir155−/− Mir146a−/− CD4+ T cells (Table S3), and 3) unchanged or repressed in aged 
Mir146a−/− CD4+ T cells. Using this stringent approach, we identified 21 candidate 
miR-155 targets putatively involved in the development of Tfh cells in Mir146a−/− mice 
(Figures 6C and 6D). We confirmed some of these by QPCR (Figure S6), and further 
validated higher expression of Peli1, Ikbke and Fosl2 at the protein level in Mir155−/−CD4+ 
T cells compared to Wt controls (Figure 6E). We also found that expression of Peli1, Fosl2 
and Ikbke was lower in Wt Tfh compared to non Tfh cells taken from immunized mice, 
while their expression values in Mir155−/− Tfh cells were similar to Wt non Tfh cells and 
well above amounts in Wt Tfh cells (Figure 6F). To confirm direct targeting of Peli1 and 
Fosl2, both genes that regulate T cell differentiation, we cloned their 3’ UTRs downstream 
from luciferase. Luciferase assays confirmed that miR-155 directly repressed protein 
expression through its binding sites in these 3’ UTRs, as repression was observed with Wt 3’ 
UTRs but not when miR-155 binding sites were mutated (Figures 6G and 6H).
Pathway analyses indicated that a subset of these targets regulate the NF-kB (Ikbke and 
Peli1) and AP-1 (Fosl2) pathways, both involved in Tfh cell development and autoimmunity 
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(Chang et al., 2011; Clark et al., 2011) (Figure 6D). Another subset of genes repressed by 
miR-155 has been shown to regulate the mTOR pathway (including Rptor, Rps6ka3, Adrb2, 
Ikbke and Nfe2l2), and there were multiple target genes involved in chromatin modifications 
(Satb1, Kat2a, Kdm7a and Nsd1) (Figure 6D). Many of these targets have been shown to 
influence T helper cell development (Figure 6D and S6).
shRNA silencing of Fosl2 in adoptively transferred Mir155−/− 2D2 TCR-transgenic CD4+ T 
cells, which are TCRVβ11+, resulted in improved Tfh cell development following 
immunization with MOG35–55 (Figure 6I–6K). Silencing of Peli1 also trended towards 
rescuing the phenotype, supporting our view that multiple miR-155 targets are likely 
involved in this process (Figure S6). Taken together, our findings suggest that miR-155 
facilitates Tfh cell accumulation during chronic, low-grade inflammation through a complex 
mechanism involving multiple target genes and signaling pathways that instruct early Tfh 
cell formation.
T cell-specific expression of miR-155 drives spontaneous Tfh and GC B cell development 
in Mir146a−/− mice
To determine the role of T cell-intrinsic miR-155 during the early stages of chronic, low-
grade inflammation, when expanded Tfh cell populations are first observed, we crossed 
Mir146a−/− mice with Cd4-cre Mir155fl/fl animals (Figure 7A). By 4 months of age we 
began to observe mild splenomegaly in Mir146a−/− mice, which was not seen in Mir146a−/− 
Cd4-cre Mir155fl/fl mice (Figure 7B). Upon further analyzing 1.5 and 4 months old 
Mir146a−/− Cd4-cre Mir155 fl/fl mice we detected reduced numbers of Tfh cells (Figures 
7C–7J and S7) and GC B cells (Figures 7K, 7L and S7) compared to the numbers found in 
age-matched Mir146a−/− mice. Further, at the 4 month time point we also noticed that early 
signs of the myeloproliferative disease that emerged as Mir146a−/− mice grew older were 
observed in Mir146a−/− but not Mir155−/− Mir146a−/− or Mir146a−/−Cd4-cre Mir155fl/fl 
mice (Figure S7). These included elevated CD11b+ and decreased Ter119+ cells in the bone 
marrow. Overall, these findings demonstrate that miR-155 plays a T cell intrinsic role in 
promoting spontaneous germinal center reactions in Mir146a−/− mice.
Discussion
The humoral response gradually loses its potency against novel, exogenous antigens and 
begins to initiate responses against self-tissues as a function of age (Dorshkind et al., 2009; 
Linterman, 2014). Our study indicates that cells with a Tfh cell phenotype may be involved 
in this age-dependent conversion, as both their numbers and downstream effects (e.g. 
increases in GC B cells) increase before the onset of autoantibody production in Mir146a−/− 
mice. This concept is also in accordance with clinical studies that report increases in the Tfh 
cell growth factors IL-6 (Akbaraly et al., 2013) and IL-21 (Agrawal et al., 2012), memory 
phenotype T cells (Moro-Garcia et al., 2013), autoantibodies (Nagele et al., 2013) and 
autoimmune disease (Yung and Julius, 2008) in some older versus younger individuals. 
During future studies, it will be important to assess both the quality and quantity of Tfh cell 
populations as a function of age in human tissues, and to determine if different features of 
Hu et al. Page 7













chronic, low-grade inflammation in human populations involves aberrations to this cellular 
population.
Mechanistically, our results identify opposing roles for miRNAs in controlling progressive, 
spontaneous Tfh cell expansion, where miR-146a restricts and miR-155 promotes this 
program in mice. This suggests that factors controlling the ratio of miR-155:miR-146a can 
influence this process. Both of these miRNAs are transcriptionally induced by inflammatory 
stimuli or T cell receptor (TCR) engagement (Haasch et al., 2002; Yang et al., 2012). 
Further, genetic variants in the miR-155 gene locus has been linked to autoimmune disease 
(Paraboschi et al., 2011), while specific polymorphisms in the passenger strand of miR-146a 
lead to reduced production of mature miR-146a (Jazdzewski et al., 2008). These 
observations indicate that both genetic and environmental factors are involved in controlling 
the concentrations of these miRNAs and thus their abilities to regulate humoral responses 
during the aging process. Furthermore, while we found a variety of age-related 
inflammatory phenotypes in Mir146a−/− mice to involve miR-155 through the use of whole 
body Mir155−/− Mir146a−/−mice, and focused on miR-155’s T cell-intrinsic role in 
promoting GC reactions in this setting, future investigation is needed to determine if 
miR-155 functions in either Tfh or non-Tfh cell types to promote other aspects of the disease 
that emerge in this model. It is also plausible that other miR-146a–dependent phenotypes are 
independent of miR-155.
In addition to its well-established function in B cells during Ig class-switching and affinity 
hyper-mutation (Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2007), our data 
identify a previously unappreciated role for miR-155 in the CD4+ T cells as they provide 
help to B cells during the germinal center reaction. In particular, we describe a decreased 
capacity by Mir155−/− CD4+ T cells to develop into the Tfh cell lineage following 
immunization, viral infection or during age-related inflammatory disease. Because we 
observe decreased Tfh cell numbers, while our expression analysis indicates that effector 
function may be intact on a per cell basis, it is possible that miR-155 is involved in Tfh cell 
differentiation and expansion as opposed to their functions once mature. Our findings also 
indicate that multiple miRNAs are involved in regulating Tfh cell biology, as recent studies 
have described roles for the miRNAs 17~92 family (Baumjohann et al., 2013; Kang et al., 
2013) and miR-10a (Takahashi et al., 2012) during Tfh cell formation.
We identified 21 direct miR-155 targets in Tfh cells that regulate critical signaling pathways 
including NF-κB, AP-1 and mTor, in addition to several genes that regulate chromatin 
modifications. Consistent with many previous studies (Hu et al., 2013; Huffaker et al., 2012; 
Loeb et al., 2012), our results continue to support a model whereby miR-155 regulates T cell 
biology through a multi-target mechanism that enables development of different T effector 
cell subsets in distinct contexts. However, it remains unclear if miR-155 targets unique sets 
of genes to regulate the distinct effector T cell lineages that it has been linked to, including 
regulatory T (Treg) cells (Lu et al., 2009), Th17 cells (Kurowska-Stolarska et al., 2011; 
O'Connell et al., 2010b), Th1 cells (Oertli et al., 2011), Th2 cells (Malmhall et al., 2013), 
and now Tfh cells, or if there is a core “targetome” that is commonly required to license the 
formation of these subtypes. This will be an important area of future research that will 
require target identification in multiple T cell types in parallel using the same technology.
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Our data also provide evidence that Fosl2, and to some extent Peli1, are functionally 
relevant miR-155 targets. Fosl2 is a repressor of CD4+ T cell plasticity (Ciofani et al., 2012) 
that binds to Jun proteins and is thought to compete with Batf for DNA binding sites. Batf-
containing AP-1 complexes bind cooperatively with IRF4 to defined DNA elements called 
AP-1-IRF composite elements (AICEs) (Glasmacher et al., 2012), and both of these factors 
are necessary for Tfh cell development (Betz et al., 2010; Bollig et al., 2012). However, 
Fosl2 containing complexes are unable to recruit IRF4 once bound to these sites 
(Glasmacher et al., 2012), pointing to a mechanistic basis for its repressive role during T cell 
differentiation. Thus, because Fosl2 is at higher amounts in Mir155−/− CD4+ T cells, our 
data suggest that it is able to hinder Tfh cell development by interfering with normal Batf 
and IRF4 functions. In the case of Peli1, it has been shown to inhibit NF-kB activation, 
which is also involved in the induction of Tfh cell-associated genes (Chang et al., 2011; 
Chen et al., 2010). Future work will investigate these connections further, and determine 
their relevance in other Th cell lineages, including Th17 and Treg cells where miR-155 and 
Fosl2 have been shown to have opposing function.
Finally, our observations have many translational implications with relevance to human 
disease. First, the relative expression of miR-155 and miR-146a in middle-aged individuals 
might have predictive, diagnostic or prognostic value in the context of chronic, low-grade 
inflammation. Next, therapeutic targeting of miR-155 or miR-146a with antisense 
oligonucleotides in patients with chronic, low-grade inflammation could be an effective 
strategy to reduce certain disorders that stem from aberrant humoral responses. Conversely, 
from a vaccine development standpoint, these findings indicate that manipulation of 
miR-155 in both T and B cells might have a synergistic effect on the production of high 




All experiments were approved by the University of Utah Institutional Animal Care and Use 
Committee (IACUC). Mir155−/− Mir146a−/− (DKO) mice were generated as previously 
described (Huffaker et al., 2012). Mir155fl/fl mice were generated at Taconic and crossed 
with Cd4-cre mice to create Cd4-cre Mir155 fl/fl mice. Additionally, Mir146a −/− mice were 
crossed with Cd4-cre Mir155fl/fl mice to generate Mir146a−/− Cd4-cre Mir155fl/fl mice, and 
Wt SMARTA TCR Tg+ mice were crossed with Mir155−/− mice to generate Mir155−/− 
SMARTA TCR Tg+. Mir155−/− 2d2 TCR Tg+ mice were described previously (Hu et al., 
2013).
Flow Cytometry
Fluorophor-conjugated antibodies against the indicated surface markers were used to stain 
RBC-depleted splenocytes, LN cells, BM cells and peripheral blood cells. For intracellular 
staining, cells were first surface stained for lineage markers, fixed, permeabilized and 
stained with antibodies against Bcl6, IL-17A, IFNγ, or Ki67 (Biolegend). Stained cells were 
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analyzed using a BD LSR Fortessa flow cytometer, and further data analysis was carried out 
using FlowJo software.
Bone marrow reconstitution
RBC-depleted bone marrow cells from Wt mice expressing the congenic marker CD45.1 
were mixed with bone marrow from Wt, miR155−/−, Mir146a−/−, or Mir155−/−Mir146a−/− 
mice expressing CD45.2 in equal proportions and injected into lethally irradiated (1050 
Rads) Wt mice expressing CD45.1, similar to (O'Connell et al., 2010a).
Adoptive transfer of SM T cells and VACV-gpc infection
Untouched naive (Thy1.1+CD44lo) CD4+ T cells were isolated from Wt or Mir155−/− 
SMARTA mice (SM T cells) using magnetic beads, per the manufacturer’s instructions 
(Stem cell technology), and injected intravenously into C57BL/6 mice. The next day mice 
were infected with recombinant Vaccinia virus that expresses the LCMV glycoprotein 
(referred to as VACV-gpc). For CFSE labeling, T cells were incubated with 0.625 µM CFSE 
(final concentration) for 10 minutes and washed with FBS before adoptive transfer. 7-AAD 
staining was used to determine viability.
Adoptive transfer of shRNA expressing 2d2 TCR Tg CD4+ T cells and MOG35–55 
Immunization
Untouched naive CD44lo CD4+ T cells were injected intravenously into B6 mice following 
spin infection with control or shRNA retroviral vectors, as described (Hu et al., 2013). The 
sequences targeting Fosl2 and Peli1 are shown in Table S4. The next day the mice were 
immunized with MOG35–55 (0.5 mg/ml) emulsified in complete Freund's adjuvant (CFA) at 
the base of the tail (200 µl each mouse), as described (Hu et al., 2013).
ELISAs
Titers of autoantibodies against dsDNA in the serum of aged mice were measured using a 
commercial ELISA test (BioVendor) according to the manufacturer’s protocol. Serum from 
Ova-immunized mice (0.5 mg/ml emulsified in complete Freund's adjuvant) was also 
collected, and Ova antigen-specific IgG and IgG1 antibodies were measured by ELISA, as 
described (O'Connell et al., 2010b).
QPCR
Sybrgreen-based quantitative real-time PCR (QPCR) was conducted to assay relative 
mRNA amounts using the Light Cycler 480 PCR system (Roche) and gene-specific primers 
(Table S4). For mature miR-155 and miR-146a expression analyses, gene-specific primers 
were purchased from Exiqon. 5S or L32 were used to normalize.
RNA Sequencing
For both experiments, total RNA was isolated using the miRNeasy kit (Qiagen). Stranded 
RNA sequencing (following RiboZero treatment and library preparation) was conducted 
using Illumina HiSeq 2000 Sequencing and carried out by the University of Utah core 
facility (https://bioserver.hci.utah.edu/microarrayweb/ordering.html). The analysis approach 
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is described in our supplemental methods. All RNA Seq data has been deposited into the 
NCBI GEO database under the accession number GSE58373.
Immunoblotting
Cell extracts were subjected to gel electrophoresis and transferred onto a nitrocellulose 
membrane followed by antibody staining and detection of Peli1, Ikbke, Fosl2, βActin or 
αTubulin, as described (Hu et al., 2013).
Luciferase Assay
The 3’ UTR regions of mouse Fosl2 and Peli1 that contain the miR-155 binding sites, or 
mutant versions, were synthesized by GeneArt technology (Life Technologies) and cloned 
into pMiR reporter plasmid. Experiments were performed using 293T cells, as described 
(Hu et al., 2013).
Histological analyses
Tissue preparation and H&E staining were performed as described previously (O'Connell et 
al., 2008). IHC was performed with antibodies against B220, CD3, and BCl6 or PNA.
Statistical Analysis
Statistical significance was determined by performing an unpaired t test using Graphpad 
Prism. All quantitative data are reported as mean ± SEM or mean. Significance is denoted as 
*** P ≤0.001, ** P ≤0.01, * P ≤0.05, and ns P>0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. miR-155 is required for expansion of CD4+ T cells with a Tfh cell gene expression 
profile in middle-aged Mir146a−/− mice
(A) Spleen weights from 2 (young) and 10 (middle-age) month-old age- and sex-matched 
Wt, miR155−/−, Mir146a−/− and Mir155−/− Mir146a−/− (DKO) mice. (B) Representative 
FACS analysis of activated (CD69+CD62L) CD4+ T cells in the spleens and lymph nodes of 
10-months old mice. (C) Spleen data from multiple young and middle-aged mice in (B). (D) 
miR-155 expression in young and middle-aged CD4+ T cells of the indicated genotypes 
(n=3). (E) CD4+CD3+CD62lloCD44+ (activated) and CD4+CD3+CD62lhiCD44 (naïve) cells 
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were sorted from 10-month old mouse spleens and miR-155 expression was assayed. (F) 
miR-155 expression in activated CD4+ T cells cultured with or without an NF-ΚB inhibitor 
(Bay 11-7082) at the indicated concentration (2.5 or 5 µM) for 24 hours. (G) Total RNA was 
extracted from splenic CD4+ T cells taken from 10-month old mice of the indicated 
genotypes and subjected to an RNA-Seq analysis (n=3). Gene clustering of RNA-Seq data is 
shown. The magnitude of the gene expression differences between any two groups is 
indicated by color, and the scale is shown. (H) Relative mRNA expression of IL21, IFN-γ, 
IL17A and miR-155 in CD4+ T cells from middle-aged Wt and Mir146a−/− mice. (I) Heat 
map indicating the fold change in Tfh cell gene expression between Mir146a−/−, Mir155−/− 
or Mir155−/− Mir146a−/− compared to Wt cells. The color key is shown. (J) QPCR analyses 
of Tfh-related genes in aged CD4+ T cells. The values have been normalized to L32. * 
denotes a p value of <0.05 using a Student’s t test. Dashed line indicates that young and 
middle-aged mice were harvested on different days, and each dot represents an individual 
mouse. See also Figure S1.
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Figure 2. miR-155-dependent accumulation of Tfh cells, GC B cells and autoantibodies in 
Mir146a−/− mice
(A) Flow cytometry plots showing CD4+CXCR5+PD1+ Tfh cells in the spleens of middle-
aged mice. (B) Average total number of Tfh cells in the spleens of middle-aged mice 7–10 
months old. (C) Flow cytometry plots showing CD4+ICOS+PD1+ Tfh cells in the spleens of 
middle-aged mice. (D) Average percentage of CD4+ICOS+PD1+ Tfh cells in the spleens of 
middle-aged mice. (E) Bcl6 expression in Tfh and non-Tfh cells in the spleens of middle-
aged mice. (F) CD4+CXCR5+PD1+ Tfh or CD4+CXCR5−PD1− non-Tfh cells were sorted 
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from the spleens of middle-aged mice and miR-155 expression was tested. (G) Average 
percentage of Tfh cells in the spleens of young and middle-aged mice. (H) Flow cytometry 
plots showing B220+IgDloGL7hiFAShi GC B cells in the spleens of middle-aged mice. (I) 
Average total number of GC B cells in the spleens of middle-aged mice. (J) Average 
percentage of GC B cells in the spleens of young and middle-aged mice. (K) ELISA of anti-
dsDNA autoantibodies in the serum of young and middle-aged mice. Error bars represent +/
− SEM. * denotes a p value of <0.05 using a Student’s T test. Dashed line indicates that 
young and middle-aged mice were harvested on different days, and each dot represents an 
individual mouse. Data represent at least two independent experiments. See also Figure S2.
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Figure 3. Histological assessment of miR-155-dependent, spontaneous GC formation and chronic 
inflammatory disease in Mir146a−/− mice
(A) Representative H&E stained sections of Wt, Mir155−/−Mir146a−/− and 
Mir155−/−Mir146a−/− (DKO) male mouse spleens from the indicate ages. Black arrows 
represent examples of germinal center elements including large centroblasts, mitotic figures 
and apoptotic bodies. Red arrowheads represent myeloid cells. Scale bar: 40 microns. B. 
Spleen sections from 1.5 month-old mice were also subjected to IHC to detect T cells 
(CD3), B cells (B220) and BCL6+ cells. Arrows indicate regions with BCL6 positive cells. 
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Scale bar: 400 microns. (C) Representative PNA staining of spleens from Mir146a−/− and 
Mir155−/−Mir146a−/− mice at 1.5 months of age. Scale bar: 100 microns. (D) The number of 
GCs per splenic lymphoid follicle was determined at 1.5 and 4 months of age. (E) CD11b+ 
myeloid cell numbers were measured using flow cytometry. (F) Representative H&E 
staining of kidneys and livers from Mir146a−/− and Mir155−/− Mir146a−/− mice at 12 
months of age. Scale bar: 100 microns. Inflammatory infiltrate is located within the dashed 
boarder. * denotes a p value of <0.05 using a Student’s T test. See also Figure 3S.
Hu et al. Page 20













Figure 4. T cell-intrinsic role for miR-155 during Tfh cell development and T-dependent 
humoral responses
(A) Schematic diagram showing the loxP sites flanking the miR-155 hairpin sequence in 
miR-155fl/fl mice, and location of genotyping primers. (B) Genomic DNAs were isolated 
from flow cytometry sorted CD4+CD3ε+ T and B220+ cells from the indicated mouse 
spleens and the primers that flank the 5’ loxP site were used for PCR. A representative 
agarose gel is shown to demonstrate T cell specific deletion of miR-155. (C) CD4+ T, CD8+ 
T and B220+ B cells were isolated from the indicated mouse spleens by flow cytometry 
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sorting and expression of mature miR-155 by each cell type was assayed by QPCR. (D-L) 
The indicated mice were immunized with Ova in CFA. Following 8 days, spleens and LNs 
were isolated and subjected to staining with the indicated antibodies and analyzed by flow 
cytometry. (D) Representative FACS plots showing CD4+CXCR5+PD1+ Tfh cells in the 
spleens (upper panel) and LNs (lower panel). (E and F) Average percentage of Tfh cells in 
spleens (E) and LNs (F). (G) Bcl6 expression in Tfh and non-Tfh cells in the spleens of the 
indicated mice. (H) Flow cytometry plots showing GC B cells in the spleens. (I and J) 
Average percentage (I) or total number (J) of B220+IgDloFashiGL7hi GC B cells in the 
spleens. (K and L) Relative serum amounts of Ova-specific IgG1 antibodies in OVA 
immunized mice from the indicated time points and genotypes (D=Day). Error bars 
represent +/− SEM. * denotes a p value of <0.05 using a Student’s t test. Data represent at 
least three independent experiments. See also Figures 4S and 5S.
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Figure 5. Robust Tfh cell differentiation by naïve antigen specific CD4+ T cells in response to 
VACV-gpc infection requires miR-155
8×104 (D3) or 2×104 (D5) Wt or Mir155−/− SM cells were transferred into B6 Wt mice 
which were infected with VACV-gpc the following day. Mice were analyzed at D3 or D5 
post-infection. (A-B) Representative flow cytometry plots showing the percentage of Wt and 
Mir155−/−CD4+Thy1.1+ SM cells (left panel) and percentage of CXCR5+PD1+ Tfh cells 
within this population (right panel), in the spleens at the indicated time point. (C) Average 
percentage of SM T cells, or Tfh cells within this population, in the spleens at the indicated 
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time points post-infection. (D) Representative histogram of Bcl6 or Ki67 staining of Wt or 
Mir155−/− SM cells at the 3-day time point. The average MFI of each stain is shown to the 
right. (E) Representative histogram showing CFSE expression by Wt or Mir155−/− SM Tfh 
cells at 3 days post infection. (F) The average percentage of Tfh cells having entered the 6th 
cell division. * denotes a p value of <0.05 using a Student’s t test. Data represent at least two 
independent experiments. See also Figure 5S.
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Figure 6. Identification of Tfh cell-relevant miR-155 target genes in CD4+ T cells from middle-
aged mice
(A) QPCR analyses of mature miR-155 and BCL6 mRNA expression in sorted Tfh and non-
Tfh cells from the indicated mouse spleens following immunization. (B) Pie charts 
indicating the percentage of genes that are upregulated (>1.2) or downregulated (<0.8) in 
Mir155−/− vs. Wt Tfh cells based on all genes in the dataset or specifically miR-155 targets 
genes. (C) Venn diagram showing the number of common miR-155 targets in purified Tfh 
cells and CD4+ T cells from middle-aged mice. (D) Genes targeted by miR-155 according to 
Hu et al. Page 25













the overlap in (C). Bars represent relative fold change of gene expression in the mutant cells 
compared to Wt controls based on RNA-Seq data. Boxes indicate different pathways in 
which these genes function, and * denotes that a role for the gene has been described in T 
cell differentiation. (E) Representative Western blot analysis of Peli1, Ikbke, Fosl2 and 
αTubulin expression in activated Wt and Mir155−/− CD4+ T cells (left). Quantification of 
Peli1 (n=9), Ikbke (n=6) and Fosl2 (n=4) expression in T cells from multiple mice 
normalized to αTubulin (right). (F) Relative expression of Fosl2, Peli1 and Ikbke in sorted 
CD4+ non Tfh and Tfh cells from OVA immunized Wt and Mir155−/− mice based on RNA-
Seq. (G) Luciferase reporter assays demonstrating direct repression of the 3’ UTRs by 
miR-155. For Fosl2, the mutant 3’ UTR has both sites disrupted. (H) Schematic layout of 
the 3’ UTR sequence of mouse Fosl2 and Peli1 and the seed region (yellow) where miR-155 
is predicted to bind. Mutant sequence is shown in green. (I) Representative Western blot 
analysis of Fosl2 expression in activated Wt CD4+ T cells after silencing with a shFosl2 
expressing retroviral vector. (J) Representative flow cytometry plots showing the percentage 
of CXCR5+PD1+ Tfh cells among CD3+CD4+Vβ11+GFP+ cells in the spleens following 7 
days of immunization with MOG35–55. (K) Average percentage of Tfh cells among 
CD3+CD4+Vβ11+GFP+ cells from (I). Error bars represent +/− SEM. * denotes a p value of 
<0.05 using a Student’s t test. See also Figure 6S.
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Figure 7. T cell-intrinsic miR-155 is required for Tfh cell expansion in Mir146a−/− mice
(A) Genotyping gel confirming the creation of Mir146a−/− CD4-Cre: miR-155fl/fl mice. (B) 
Spleen weights from 4 month old mice of the indicated genotypes. (C) Flow cytomtery plots 
showing CD3+CD4+CXCR5+PD1+ Tfh cells in the spleens of 1.5-month or (D) 4-month old 
mice. (E) Representative flow cytomtery plots of CD3+CD4+ICOS+PD1+ Tfh cells from 4-
month old spleens (F) Histogram showing Bcl6 expression by Tfh and non-Tfh cells in the 
spleens of the indicated genotypes at 4 months of age. (G-J) Average values for multiple 
mice from (C-F). (K) Flow cytometry plots showing B220+IgDloFashiGL7hi GC B cells in 
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the spleens of the indicated mice at the 1.5 and 4 month time points. (L) Average total 
number of GC B cells in the spleens from (K). Error bars represent +/− SEM. * denotes a p 
value of <0.05 using a Student’s t test. Data represent two independent experiments. See 
also Figure 7S.
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